Ann Mullally
@mullallylab.bsky.social
Heme Chief at Stanford. Physician Scientist studying myeloid malignancies. Views my own.
Reposted by Ann Mullally
You don’t need a brain to benefit from a good night of sleep. Despite lacking a central nervous system, jellyfish and sea anemones have sleep patterns remarkably similar to those of humans, researchers report.
Learn more: https://scim.ag/3NgeAEQ
Learn more: https://scim.ag/3NgeAEQ
January 8, 2026 at 5:15 PM
You don’t need a brain to benefit from a good night of sleep. Despite lacking a central nervous system, jellyfish and sea anemones have sleep patterns remarkably similar to those of humans, researchers report.
Learn more: https://scim.ag/3NgeAEQ
Learn more: https://scim.ag/3NgeAEQ
Reposted by Ann Mullally
Nature research paper: Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit
go.nature.com/45m7t4b
go.nature.com/45m7t4b
Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit - Nature
Integrated single-cell and spatial data analysis, combined with bidirectional CRISPR screens, identify the transcription factor GLIS3 as a key driver of chronic inflammation and fibrosis and a potential marker of disease severity in patients with ulcerative colitis.
go.nature.com
January 8, 2026 at 7:26 PM
Nature research paper: Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit
go.nature.com/45m7t4b
go.nature.com/45m7t4b
Reposted by Ann Mullally
Now online in Cancer Discovery @aacrjournals.bsky.social: Genotype-to-Phenotype Mapping of Somatic Clonal Mosaicism via Single-Cell Co-Capture of DNA Mutations & mRNA Transcripts by @dennisjyuan.bsky.social, @landau.bsky.social, et al. doi.org/10.1158/2159... @nygenome.org @weillcornell.bsky.social
January 7, 2026 at 2:51 PM
Now online in Cancer Discovery @aacrjournals.bsky.social: Genotype-to-Phenotype Mapping of Somatic Clonal Mosaicism via Single-Cell Co-Capture of DNA Mutations & mRNA Transcripts by @dennisjyuan.bsky.social, @landau.bsky.social, et al. doi.org/10.1158/2159... @nygenome.org @weillcornell.bsky.social
Reposted by Ann Mullally
We're excited to share that Blood Advances has a new Associate Editor, Dr. Steven Lane. He's a clinical hematologist and researcher at Royal Brisbane & Women's Hospital and runs a busy research group at the Queensland Institute of Medical Research. Welcome Dr. Lane! #BloodAdvances
January 7, 2026 at 2:44 PM
We're excited to share that Blood Advances has a new Associate Editor, Dr. Steven Lane. He's a clinical hematologist and researcher at Royal Brisbane & Women's Hospital and runs a busy research group at the Queensland Institute of Medical Research. Welcome Dr. Lane! #BloodAdvances
Reposted by Ann Mullally
The MPN Challenge™ funding cycle is now open. Find further details on eligibility, proposal guidelines, and deadlines. https://goto.mpnresearchfoundation.org/49ixqCH. Proposals are due by March 23, 2026 at 11:59PM CT. #2026MPNChallenge #MPNChallenge #RFA #MPNFundingOpportunity #MPNRF
January 7, 2026 at 12:04 AM
The MPN Challenge™ funding cycle is now open. Find further details on eligibility, proposal guidelines, and deadlines. https://goto.mpnresearchfoundation.org/49ixqCH. Proposals are due by March 23, 2026 at 11:59PM CT. #2026MPNChallenge #MPNChallenge #RFA #MPNFundingOpportunity #MPNRF
Reposted by Ann Mullally
Papers submitted on Tuesdays are more likely to be accepted by Nature whereas Wednesdays seem the most likely day to submit and secure acceptance to PLOS ONE. For Cell, Mondays and Tuesdays seem the best submission days in case of accepted papers.
link.springer.com/article/10.1...
link.springer.com/article/10.1...
January 6, 2026 at 10:09 PM
Papers submitted on Tuesdays are more likely to be accepted by Nature whereas Wednesdays seem the most likely day to submit and secure acceptance to PLOS ONE. For Cell, Mondays and Tuesdays seem the best submission days in case of accepted papers.
link.springer.com/article/10.1...
link.springer.com/article/10.1...
Fascinating study on Anna’s hummingbird, one of the many beautiful birds I frequently see on the Stanford campus! 🐦 @stanforduniversity.bsky.social
Evolution doesn’t always take thousands or millions of years. Sometimes it happens right before our eyes.
Such is the case with the Anna’s hummingbird, a species that has undergone a dramatic transformation in a few generations, thanks to the advent of hummingbird feeders: https://scim.ag/3YMuQQu
Such is the case with the Anna’s hummingbird, a species that has undergone a dramatic transformation in a few generations, thanks to the advent of hummingbird feeders: https://scim.ag/3YMuQQu
January 6, 2026 at 3:32 PM
Fascinating study on Anna’s hummingbird, one of the many beautiful birds I frequently see on the Stanford campus! 🐦 @stanforduniversity.bsky.social
Excited to kick off 2026 with a #Hematology seminar from Arun Wiita, MD, PhD on Jan 8th! Arun has pioneered proteomics to characterize aberrantly expressed cell surface proteins in #bloodcancers, to identify novel targets for #immunotherapy, looking forward to this! @stanforddeptmed.bsky.social
January 5, 2026 at 7:34 PM
Excited to kick off 2026 with a #Hematology seminar from Arun Wiita, MD, PhD on Jan 8th! Arun has pioneered proteomics to characterize aberrantly expressed cell surface proteins in #bloodcancers, to identify novel targets for #immunotherapy, looking forward to this! @stanforddeptmed.bsky.social
Reposted by Ann Mullally
Coming next week on The Future of Medicine: Jennifer Doudna, a Nobel Prize–winning biochemist & the co-inventor of CRISPR gene editing! #StanDOM's @euanashley.bsky.social & Doudna discuss scientific curiosity, responsible innovation, gene editing & more. https://bit.ly/43LGRZv
December 12, 2025 at 7:10 PM
Coming next week on The Future of Medicine: Jennifer Doudna, a Nobel Prize–winning biochemist & the co-inventor of CRISPR gene editing! #StanDOM's @euanashley.bsky.social & Doudna discuss scientific curiosity, responsible innovation, gene editing & more. https://bit.ly/43LGRZv
Reposted by Ann Mullally
At a recent #MedicineGrandRounds, @childrensphila.bsky.social's Alexis Thompson discussed her groundbreaking research on #SickleCellDisease. Her clinical research was instrumental in the approval of the first gene therapies for sickle cell disease.
📸 by Clinton Louie
📸 by Clinton Louie
December 11, 2025 at 5:08 PM
At a recent #MedicineGrandRounds, @childrensphila.bsky.social's Alexis Thompson discussed her groundbreaking research on #SickleCellDisease. Her clinical research was instrumental in the approval of the first gene therapies for sickle cell disease.
📸 by Clinton Louie
📸 by Clinton Louie
Reposted by Ann Mullally
Today's the print release of a #RibackLab and #GoodellLab collaboration— we’re excited to share the visual story behind the science, including the dramatic artwork that inspired how we thought about aberrant function of NPM1c - which occurs in about 1 in 3 adult acute myeloid leukemias (#AML).
December 12, 2025 at 12:03 AM
Today's the print release of a #RibackLab and #GoodellLab collaboration— we’re excited to share the visual story behind the science, including the dramatic artwork that inspired how we thought about aberrant function of NPM1c - which occurs in about 1 in 3 adult acute myeloid leukemias (#AML).
Reposted by Ann Mullally
One of my favorite pics of the Myeloid Workshop at #ASH2025. Not at all challenging to find female speakers; thanks to ASH and the excellent section leaders for making this happen!
December 9, 2025 at 4:25 PM
One of my favorite pics of the Myeloid Workshop at #ASH2025. Not at all challenging to find female speakers; thanks to ASH and the excellent section leaders for making this happen!
Reposted by Ann Mullally
The gavel has officially passed at #ASH25. Thank you, Dr. Avalos, for your outstanding leadership. And welcome to Dr. Robert Negrin, whose dedication to mentorship, discovery, and advancing hematology will continue to strengthen the field.
December 9, 2025 at 8:28 PM
The gavel has officially passed at #ASH25. Thank you, Dr. Avalos, for your outstanding leadership. And welcome to Dr. Robert Negrin, whose dedication to mentorship, discovery, and advancing hematology will continue to strengthen the field.
Reposted by Ann Mullally
There’s an art to writing a grant proposal so that your creativity is on full display. Maria Leptin - president of the ERC - talks about it on the new episode of the Night Science Podcast.
December 9, 2025 at 4:36 AM
There’s an art to writing a grant proposal so that your creativity is on full display. Maria Leptin - president of the ERC - talks about it on the new episode of the Night Science Podcast.
Such a great event! #ASH25
The biggest #ASHRunWalk yet! 🏃🏃♀️🎉 So many showed up for the 3K/5K running with purpose to protect research and the future of hematology. Congrats to every runner who made this morning unforgettable. #ASH25 #Fight4Hematology
December 7, 2025 at 2:19 PM
Such a great event! #ASH25
Reposted by Ann Mullally
Lachelle Weeks, MD, PhD, shares findings that demonstrate sickle cell disease may predispose patients to high-risk clonal hematopoiesis. This multinational cohort defined CH prevalence, age distribution, and mutational profiles in SCD relative to non‐SCD controls and other hemoglobinopathies. #ASH25
December 6, 2025 at 2:58 PM
Lachelle Weeks, MD, PhD, shares findings that demonstrate sickle cell disease may predispose patients to high-risk clonal hematopoiesis. This multinational cohort defined CH prevalence, age distribution, and mutational profiles in SCD relative to non‐SCD controls and other hemoglobinopathies. #ASH25
Reposted by Ann Mullally
EBV & Lupus — A Breakthrough Publication of 2025
Announced in Nov. 2025, a landmark Science Translational Medicine study from #StanDOM's William H. Robinson revealed how the common Epstein-Barr virus can infect & reprogram immune cells to trigger lupus. https://stanford.io/3LUx3Gg
Announced in Nov. 2025, a landmark Science Translational Medicine study from #StanDOM's William H. Robinson revealed how the common Epstein-Barr virus can infect & reprogram immune cells to trigger lupus. https://stanford.io/3LUx3Gg
December 4, 2025 at 8:14 PM
EBV & Lupus — A Breakthrough Publication of 2025
Announced in Nov. 2025, a landmark Science Translational Medicine study from #StanDOM's William H. Robinson revealed how the common Epstein-Barr virus can infect & reprogram immune cells to trigger lupus. https://stanford.io/3LUx3Gg
Announced in Nov. 2025, a landmark Science Translational Medicine study from #StanDOM's William H. Robinson revealed how the common Epstein-Barr virus can infect & reprogram immune cells to trigger lupus. https://stanford.io/3LUx3Gg
Reposted by Ann Mullally
“I had hemophilia for nearly five decades. I went to Philadelphia and had a 45-minute infusion, and my hemophilia was gone.”
Genes-> Medicine
nature.com/articles/s41...
Genes-> Medicine
nature.com/articles/s41...
November 21, 2025 at 9:45 PM
“I had hemophilia for nearly five decades. I went to Philadelphia and had a 45-minute infusion, and my hemophilia was gone.”
Genes-> Medicine
nature.com/articles/s41...
Genes-> Medicine
nature.com/articles/s41...
Ah, how I miss New England! 🥶 🤣
Officials at the Mount Washington Observatory said that they were bracing for an “extreme cold and wind event” set to hit New England Thursday that could break records on the summit.
‘Brutal.’ Officials on summit of Mt. Washington brace for extreme ‘cold and wind’ event - The Boston Globe
“It is most certainly going to be near or setting a new overnight temperature record,” Globe meteorologist Ken Mahan said. “It’s going to make the summit of Mt. Washington feel like Siberia.”
trib.al
December 4, 2025 at 12:03 AM
Ah, how I miss New England! 🥶 🤣
#ASH25 is almost here and the latest #ASHinaFlash has everything you need to know about clonal hematopoiesis before you arrive. Dr. Peter van Galen's session explores how clonal hematopoiesis influences leukemia risk, cardiovascular health, and more.
Register today: https://ow.ly/6pbU50XyfqN
Register today: https://ow.ly/6pbU50XyfqN
November 26, 2025 at 5:40 PM
Very interesting! 🧬
A 60-year old man in Germany became the seventh person with HIV to be announced free of the virus after receiving a stem-cell transplant
go.nature.com/48C68Ib
go.nature.com/48C68Ib
Seventh patient ‘cured’ of HIV: why scientists are excited
A man in Germany is HIV-free after receiving stem cells that are not resistant to the virus.
go.nature.com
November 26, 2025 at 5:39 PM
Very interesting! 🧬
Reposted by Ann Mullally
Here's your first look at The Future of Medicine, our new #StanDOM podcast launching Dec. 1! Meet host @euanashley.bsky.social & hear more about the exciting paths we will chart together!
Subscribe anywhere you listen to podcasts or watch on YouTube at https://bit.ly/44vtyMX
Subscribe anywhere you listen to podcasts or watch on YouTube at https://bit.ly/44vtyMX
November 25, 2025 at 12:01 AM
Here's your first look at The Future of Medicine, our new #StanDOM podcast launching Dec. 1! Meet host @euanashley.bsky.social & hear more about the exciting paths we will chart together!
Subscribe anywhere you listen to podcasts or watch on YouTube at https://bit.ly/44vtyMX
Subscribe anywhere you listen to podcasts or watch on YouTube at https://bit.ly/44vtyMX
Reposted by Ann Mullally
The highly anticipated #ASH25 late-breaking abstracts have been posted: https://ow.ly/EGCi50XwYbf
👏 #ASHKudos to the presenters!
Discover more important and novel research at the 67th ASH Annual Meeting. It's not too late to register! #Hemesky #Medsky
👏 #ASHKudos to the presenters!
Discover more important and novel research at the 67th ASH Annual Meeting. It's not too late to register! #Hemesky #Medsky
November 24, 2025 at 5:01 PM
The highly anticipated #ASH25 late-breaking abstracts have been posted: https://ow.ly/EGCi50XwYbf
👏 #ASHKudos to the presenters!
Discover more important and novel research at the 67th ASH Annual Meeting. It's not too late to register! #Hemesky #Medsky
👏 #ASHKudos to the presenters!
Discover more important and novel research at the 67th ASH Annual Meeting. It's not too late to register! #Hemesky #Medsky
This was an amazing MGR presentation!
@stanforddeptmed.bsky.social
@stanforddeptmed.bsky.social
Stanford Bioengineering's Mark Skylar-Scott shared his 3D bioprinting work at #StanDOM's Medicine Grand Rounds, creating vascularized heart tissues & scaling stem-cell-based organ fabrication to bring lab breakthroughs to clinical care.
November 24, 2025 at 6:18 PM
This was an amazing MGR presentation!
@stanforddeptmed.bsky.social
@stanforddeptmed.bsky.social
Now online in Cancer Discovery @aacrjournals.bsky.social: DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated with Increased LSC Frequency - by Thomas Köhnke, Daiki Karigane, Ravi Majeti, et al. doi.org/10.1158/2159... @stanfordmedicine.bsky.social
November 24, 2025 at 3:55 PM